Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

January 7, 2026

Study Completion Date

December 31, 2026

Conditions
Cancer
Interventions
DRUG

Durvalumab

Fixed dose of 1500 mg via IV infusion upon enrollment visit and every 4 weeks thereafter.

Trial Locations (130)

112

Research Site, Taipei

333

Research Site, Taoyuan District

404

Research Site, Taichung

704

Research Site, Tainan City

1083

Research Site, Budapest

1101

Research Site, Quezon City

1612

Research Site, Sofia

1618

Research Site, Sofia

3000

Research Site, Melbourne

3128

Research Site, Box Hill

6000

Research Site, Charleroi

8000

Research Site, Székesfehérvár

9024

Research Site, Győr

10330

Research Site, Bangkok

13005

Research Site, Marseille

14564

Research Site, Athens

15706

Research Site, Santiago de Compostela

16059

Research Site, Bursa

17007

Research Site, Girona

20133

Research Site, Milan

20141

Research Site, Milan

20230

Research Site, Aguascalientes

21029

Research Site, Vinnytsia

21079

Research Site, Dijon

25030

Research Site, Besançon

26121

Research Site, Oldenburg

28046

Research Site, Madrid

29200

Research Site, Brest

29603

Research Site, Marbella

31059

Research Site, Toulouse

33076

Research Site, Bordeaux

33332

Research Site, Gütersloh

34090

Research Site, Montpellier

34098

Research Site, Istanbul

35042

Research Site, Rennes

35100

Research Site, Izmir

35128

Research Site, Padua

37044

Research Site, Tours

38120

Research Site, Memphis

41125

Research Site, Modena

44805

Research Site, Saint-Herblain

46009

Research Site, Valencia

47014

Research Site, Meldola

48149

Research Site, Münster

49102

Research Site, Dnipro

49241

Research Site, Busan

50200

Research Site, Chiang Mai

52100

Research Site, Arezzo

56126

Research Site, Pisa

58013

Research Site, Chernivtsi

61469

Research Site, Gwangju

67200

Research Site, Strasbourg

69373

Research Site, Lyon

70000

Research Site, Ho Chi Minh City

70124

Research Site, Bari

76018

Research Site, Ivano-Frankivsk

76031

Research Site, Rouen

80218

Research Site, Denver

88014

Research Site, Kyiv

Research Site, Uzhhorod

90110

Research Site, Hat Yai

92663

Research Site, Newport Beach

93200

Research Site, Kuching

94805

Research Site, Villejuif

95126

Research Site, Catania

97134

Research Site, Mérida

100000

Research Site, Hanoi

100142

Research Site, Beijing

100853

Research Site, Beijing

105229

Research Site, Moscow

110042

Research Site, Shenyang

115478

Research Site, Moscow

119074

Research Site, Singapore

168583

Research Site, Singapore

196603

Research Site, Saint Petersburg

197758

Research Site, Saint Petersburg

200030

Research Site, Shanghai

200433

Research Site, Shanghai

210009

Research Site, Nanjing

310003

Research Site, Hangzhou

310006

Research Site, Hangzhou

310009

Research Site, Hangzhou

325000

Research Site, Wenzhou

361003

Research Site, Xiamen

410013

Research Site, Changsha

600035

Research Site, Chennai

603001

Research Site, Nizhny Novgorod

630108

Research Site, Novosibirsk

644013

Research Site, Omsk

700000

Research Site, Hồ Chí Minh

710061

Research Site, Xi'an

720214

Research Site, Suceava

S2000KZE

Research Site, Rosario

14784-400

Research Site, Barretos

15090-000

Research Site, São José do Rio Preto

K7L 2V7

Research Site, Kingston

L3Y 2P9

Research Site, Newmarket

M5G 2M9

Research Site, Toronto

779 00

Research Site, Olomouc

00128

Research Site, Roma

00152

Research Site, Roma

113-8677

Research Site, Bunkyō City

812-8582

Research Site, Fukuoka

920-8641

Research Site, Kanazawa

135-8550

Research Site, Kōtoku

466-8560

Research Site, Nagoya

700-8607

Research Site, Okayama

840-8571

Research Site, Saga

411-8777

Research Site, Sunto-gun

0 3100

Research Site, Mexico City

15-027

Research Site, Bialystok

85-796

Research Site, Bydgoszcz

02-300

Research Site, Elblag

90-302

Research Site, Lodz

93-513

Research Site, Lodz

10-357

Research Site, Olsztyn

71-730

Research Site, Szczecin

02-781

Research Site, Warsaw

03080

Research Site, Seoul

03722

Research Site, Seoul

06351

Research Site, Seoul

08025

Research Site, Barcelona

08035

Research Site, Barcelona

CH-1011

Research Site, Lausanne

Unknown

Research Site, Taichung

06010

Research Site, Ankara

06590

Research Site, Ankara

06800

Research Site, Ankara

EC1A 7BE

Research Site, London

S10 2SJ

Research Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY